Search

Your search keyword '"Matos I"' showing total 498 results

Search Constraints

Start Over You searched for: Author "Matos I" Remove constraint Author: "Matos I"
498 results on '"Matos I"'

Search Results

160. Botulismo alimentar - o desafio do diagnóstico.

168. 289 Hyperinsulinemia improves memory in Alzheimer's disease

169. Effect of the sintering temperature on the properties of nanocrystalline Ca1−x Sm x MnO3 (0≤ x ≤0.4) powders

170. Oral presentations: Ferenc Bojan: young investigator award session .

184. Ploidy mosaicism and allele-specific gene expression differences in the allopolyploid Squalius alburnoides

185. Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients

187. Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

188. Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

189. Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors

190. Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials

191. Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights

192. Factores de riesgo asociados en adolescentes con malnutrición por exceso. Holguín (Cuba) 2012.

193. Alkoxylation of camphene over silica-occluded tungstophosphoric acid

194. Activated carbon as a catalyst for the synthesis of N-alkylimidazoles and imidazolium ionic liquids

195. The embracing Voronoi diagram and closest embracing number.

196. Ca-site substitution induced a metal–insulator transition in manganite CaMnO3

197. 442P Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC).

198. 573P Efficacy of immunotherapy (IT) after prior immune checkpoint inhibitors (ICIs) exposure.

199. Analysing drivers of routine and COVID-19 vaccination in migrants to develop tailored interventions.

200. Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer

Catalog

Books, media, physical & digital resources